{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:19:53Z","timestamp":1788315593601,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.vaccine.2022.05.019","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T09:25:38Z","timestamp":1652433938000},"page":"3690-3700","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increases in human papillomavirus vaccine coverage over 12\u00a0months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada"],"prefix":"10.1016","volume":"40","author":[{"given":"Catharine","family":"Chambers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinku","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"de Pokomandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Grennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor A.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Coutl\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandip","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Jollimore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lachowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane","family":"Nisenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Sauvageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell H.S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann N.","family":"Burchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2022.05.019_b0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.019_b0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/infdis\/jiy556","article-title":"Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis","volume":"219","author":"Marra","year":"2019","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.05.019_b0015","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2352-3018(21)00108-9","article-title":"Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies","volume":"8","author":"Wei","year":"2021","journal-title":"Lancet HIV"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.019_b0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford","year":"2021","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.vaccine.2022.05.019_b0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.vaccine.2022.05.019_b0035","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.05.019_b0040","unstructured":"National Advisory Committee on Immunization. Updated recommendations on human papillomavirus (HPV) vaccines: 9-valent HPV vaccine 2-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. Ottawa: Government of Canada; 2017. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/updated-recommendations-human-papillomavirus-immunization-schedule-immunocompromised-populations.html [accessed 2020 Oct 16]."},{"issue":"ACS-1","key":"10.1016\/j.vaccine.2022.05.019_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a01","article-title":"Update on Human Papillomavirus (HPV) Vaccines","volume":"38","author":"Dawar","year":"2012","journal-title":"Can Commun Dis Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0050","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/curroncol28010097","article-title":"Evolution of public health human papillomavirus immunization programs in Canada","volume":"28","author":"Goyette","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.vaccine.2022.05.019_b0055","unstructured":"Gouvernement du Qu\u00e9bec. Vaccination contre les virus du papillome humain (VPH): information \u00e0 l\u2019intention des vaccinateurs. Qu\u00e9bec: Gouvernement du Qu\u00e9bec; 2021. https:\/\/publications.msss.gouv.qc.ca\/msss\/fichiers\/2021\/21-291-02W.pdf [accessed 2021 Mar 2]."},{"issue":"27","key":"10.1016\/j.vaccine.2022.05.019_b0060","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1016\/j.vaccine.2021.05.013","article-title":"Vaccine acceptability, uptake and completion amongst men who have sex with men: a systematic review, meta-analysis and theoretical framework","volume":"39","author":"Nadarzynski","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.019_b0065","doi-asserted-by":"crossref","unstructured":"Khatra J, Sang JM, Wang C, et al. Longitudinal uptake of the human papillomavirus vaccine among gay, bisexual and other men who have sex with men in British Columbia, Canada 2012-2019. Sex Transm Infect 2021 Aug 16. [Epub ahead of print]. doi:10.1136\/sextrans-2020-054871.","DOI":"10.1136\/sextrans-2020-054871"},{"issue":"28","key":"10.1016\/j.vaccine.2022.05.019_b0070","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.vaccine.2021.05.031","article-title":"Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019","volume":"39","author":"Grewal","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.05.019_b0075","doi-asserted-by":"crossref","first-page":"106329","DOI":"10.1016\/j.ypmed.2020.106329","article-title":"Low human papillomavirus (HPV) vaccine uptake among men living with human immunodeficiency virus (HIV): cross-sectional findings from a clinical cohort","volume":"143","author":"Grewal","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2022.05.019_b0080","doi-asserted-by":"crossref","unstructured":"Yeung A, Grewal R, Bekele T, Kesler M, Brennan D, Burchell A. Experiences and attitudes towards HPV and HPV vaccination among GB2M in Ontario, Canada: results from the #iCruise study. In: 32nd International Papillomavirus Conference; 2018 Oct 2-6; Sydney, Australia.","DOI":"10.1136\/sextrans-2019-sti.625"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.019_b0085","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.17269\/s41997-021-00546-z","article-title":"Prevalence of HIV and sexually transmitted and blood-borne infections, and related preventive and risk behaviours, among gay, bisexual and other men who have sex with men in Montreal, Toronto and Vancouver: results from the Engage Study","volume":"112","author":"Hart","year":"2021","journal-title":"Can J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.019_b0090","doi-asserted-by":"crossref","first-page":"E529","DOI":"10.9778\/cmajo.20200198","article-title":"Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of the Engage cohort study","volume":"9","author":"Cox","year":"2021","journal-title":"CMAJ Open"},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.019_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25699","article-title":"Characteristics of the HIV cascade of care and unsuppressed viral load among gay, bisexual and other men who have sex with men living with HIV across Canada's three largest cities","volume":"24","author":"Moore","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.vaccine.2022.05.019_b0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent-driven sampling: a new approach to the study of hidden populations","volume":"44","author":"Heckathorn","year":"1997","journal-title":"Soc Probl"},{"key":"10.1016\/j.vaccine.2022.05.019_b0105","unstructured":"World Health Organization. Introduction to HIV\/AIDS and sexually transmitted infection surveillance. Module 4: Introduction to respondent-driven sampling. Geneva: World Health Organization; 2013. https:\/\/apps.who.int\/iris\/handle\/10665\/116864 [accessed 2020 Oct 16]."},{"key":"10.1016\/j.vaccine.2022.05.019_b0110","unstructured":"Toronto Public Health. Human papillomavirus (HPV) vaccine fact sheet. Toronto: City of Toronto; 2021. https:\/\/www.toronto.ca\/community-people\/health-wellness-care\/diseases-medications-vaccines\/human-papillomavirus-hpv-vaccine\/ [accessed 2021 Oct 14]."},{"issue":"48","key":"10.1016\/j.vaccine.2022.05.019_b0115","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1016\/j.vaccine.2014.09.033","article-title":"HPV vaccine coverage among men who have sex with men \u2013 National HIV Behavioral Surveillance System, United States, 2011","volume":"32","author":"Meites","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2022.05.019_b0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/OLQ.0000000000001008","article-title":"Trends and characteristics associated with human papillomavirus vaccination uptake among men who have sex with men in the United States, 2014\u20132017","volume":"46","author":"Loretan","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2022.05.019_b0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/OLQ.0000000000000358","article-title":"Catching up or missing out? Human papillomavirus vaccine acceptability among 18- to 26-year-old men who have sex with men in a US national sample","volume":"42","author":"Cummings","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.05.019_b0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/OLQ.0000000000000626","article-title":"Human papillomavirus vaccination among young men who have sex with men and transgender women in 2 US cities, 2012\u20132014","volume":"44","author":"Gorbach","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.019_b0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/OLQ.0000000000000408","article-title":"Predictors of human papillomavirus vaccination among young men who have sex with men","volume":"43","author":"Gerend","year":"2016","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2105\/AJPH.2014.302095","article-title":"Human papillomavirus vaccination among young adult gay and bisexual men in the United States","volume":"105","author":"Reiter","year":"2015","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/OLQ.0000000000000545","article-title":"Sexually transmitted disease testing and uptake of human papillomavirus vaccine in a large online survey of US men who have sex with men at risk for HIV infection, 2012","volume":"44","author":"Kahle","year":"2017","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.019_b0150","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1097\/QAI.0000000000001413","article-title":"Increasing human papillomavirus vaccine coverage among men who have sex with men-national HIV behavioral surveillance, United States, 2014","volume":"75","author":"Oliver","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.vaccine.2022.05.019_b0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/apc.2017.0011","article-title":"Young men's disclosure of same sex behaviors to healthcare providers and the impact on health: results from a US national sample of young men who have sex with men","volume":"31","author":"Stupiansky","year":"2017","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.vaccine.2022.05.019_b0160","unstructured":"Humeniuk R, Henry-Edwards S, Ali R, Poznyak V, Monteiro M. The Alcohol, Smoking and Substance involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010. https:\/\/www.who.int\/publications\/i\/item\/978924159938-2 [accessed 2020 Oct 16]."},{"issue":"4","key":"10.1016\/j.vaccine.2022.05.019_b0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/QAI.0b013e318256b2f6","article-title":"Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States","volume":"60","author":"Smith","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2022.05.019_b0170","series-title":"Applied logistic regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.vaccine.2022.05.019_b0175","series-title":"Applying Respondent Driven Sampling to Migrant Populations: Lessons from the Field","first-page":"84","article-title":"Analyzing data in RDS","author":"Johnston","year":"2014"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0180","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12874-019-0842-5","article-title":"Unweighted regression models perform better than weighted regression techniques for respondent-driven sampling data: results from a simulation study","volume":"19","author":"Avery","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2022.05.019_b0185","unstructured":"Milbourn H, Checchi M, Soldan K. Human papillomavirus (HPV) vaccination uptake in gay, bisexual and other men who have sex with men (MSM). National programme: 2019 annual report. London: Public Health England; 2021. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/968944\/MSM_uptake_annual_report_2019.pdf [accessed 2022 Jan 3]."},{"issue":"47","key":"10.1016\/j.vaccine.2022.05.019_b0190","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.1016\/j.vaccine.2020.08.040","article-title":"Human papillomavirus vaccination coverage among men who have sex with men-National HIV Behavioral Surveillance, United States, 2017","volume":"38","author":"McClung","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.019_b0195","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1503\/cmaj.150451","article-title":"Including males in Canadian human papillomavirus vaccination programs: a policy analysis","volume":"188","author":"Shapiro","year":"2016","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2022.05.019_b0200","unstructured":"GetGarded against HPV. Vancouver: Health Initiative for Men; 2021. https:\/\/checkhimout.ca\/get-garded\/spread-the-word\/ [accessed 2021 Dec 17]."},{"key":"10.1016\/j.vaccine.2022.05.019_b0205","unstructured":"Gouvernement du Qu\u00e9bec. Flash vigie - Bulletin qu\u00e9b\u00e9cois de vigie, de surveillance et d'intervention en protection de la sant\u00e9 publique. 2019;14(7);1-5. https:\/\/publications.msss.gouv.qc.ca\/msss\/fichiers\/flashvigie\/FlashVigie_vol14_no7.pdf [accessed 2022 Jan 3]."},{"key":"10.1016\/j.vaccine.2022.05.019_b0210","unstructured":"Public Health Ontario. Immunization coverage report for school pupils in Ontario: 2017\u201318 school year - appendix tables. Toronto: Ontario Agency for Health Protection and Promotion; 2020. https:\/\/www.publichealthontario.ca\/en\/health-topics\/immunization\/vaccine-coverage [accessed 2022 Jan 3]."},{"key":"#cr-split#-10.1016\/j.vaccine.2022.05.019_b0215.1","unstructured":"BC Centre for Disease Control. Childhood immunization coverage dashboard. Percent of children immunized by BC health region grade 6 - human papillomavirus (HPV) - males, 2019. Vancouver: BC Centre for Disease Control"},{"key":"#cr-split#-10.1016\/j.vaccine.2022.05.019_b0215.2","unstructured":"2021. http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/childhood-immunization-coverage-dashboard [accessed 2022 Jan 3]."},{"key":"10.1016\/j.vaccine.2022.05.019_b0220","unstructured":"Public Health Agency of Canada. Vaccination coverage goals and vaccine preventable disease reduction targets by 2025. Ottawa: Government of Canada; 2021. [accessed 2022 Jan 3]."},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.019_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25110","article-title":"Evidence of synergistic relationships between HIV and human papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status","volume":"21","author":"Looker","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"10.1016\/j.vaccine.2022.05.019_b0230","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1080\/21645515.2015.1112474","article-title":"HPV vaccination for MSM: synthesis of the evidence and recommendations from the Quebec Immunization Committee","volume":"12","author":"Sauvageau","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12939-019-1067-2","article-title":"Economic barriers, evidentiary gaps, and ethical conundrums: a qualitative study of physicians' challenges recommending HPV vaccination to older gay, bisexual, and other men who have sex with men","volume":"18","author":"Grace","year":"2019","journal-title":"Int J Equity Health"},{"issue":"42","key":"10.1016\/j.vaccine.2022.05.019_b0240","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1016\/j.vaccine.2015.08.072","article-title":"Immunogenicity and safety of Gardasil among mid-adult aged men (27\u201345 years) \u2013 The MAM Study","volume":"33","author":"Giuliano","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.05.019_b0245","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(21)00327-3","article-title":"Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Goldstone","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.05.019_b0250","unstructured":"Meites E, Amiling R, Winer R, et al. Vaccine effectiveness against anal HPV infection among men who have sex with men - United States, 2018-2020. In: 34th International Papillomavirus Conference; 2021 Nov 15-19; virtual."},{"issue":"37","key":"10.1016\/j.vaccine.2022.05.019_b0255","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1016\/j.vaccine.2013.06.041","article-title":"Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors?","volume":"31","author":"Rolnick","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2022.05.019_b0260","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/OLQ.0000000000001503","article-title":"Sensitivity of self-reported human papillomavirus vaccination history among 18- to 26-year-old men who have sex with men: Seattle, WA, 2016 to 2018","volume":"49","author":"Forward","year":"2022","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2022.05.019_b0265","first-page":"79","article-title":"Probability-based estimation theory for respondent driven sampling","volume":"24","author":"Volz","year":"2008","journal-title":"J Off Stat"},{"issue":"12","key":"10.1016\/j.vaccine.2022.05.019_b0270","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jclinepi.2015.04.002","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: \u201cSTROBE-RDS\u201d statement","volume":"68","author":"White","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"39","key":"10.1016\/j.vaccine.2022.05.019_b0275","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2021.08.044","article-title":"Continuity of routine immunization programs in Canada during the COVID-19 pandemic","volume":"39","author":"Sell","year":"2021","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:45Z","timestamp":1759403745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22005904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":56,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0264410X22005904"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.019","relation":{"has-preprint":[{"id-type":"doi","id":"10.32920\/25460974","asserted-by":"object"},{"id-type":"doi","id":"10.32920\/25460974.v1","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increases in human papillomavirus vaccine coverage over 12\u00a0months among a community-recruited cohort of gay, bisexual, and other men who have sex with men in Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}